Carbohydrate-based vaccines for oncotherapy

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Cancer poses a significant global health threat.
• Aberrant glycosylation patterns on cancer cells serve as biomarkers for cancer development.
• Tumor-associated carbohydrate antigens (TACAs) are promising targets for cancer immunotherapy.

Purpose of the Study:

• To review the latest advancements in TACAs-based anticancer vaccines.
• To highlight strategies for overcoming the poor immunogenicity and immunotolerance associated with TACAs.
• To provide an overview of the current landscape of TACAs-based cancer immunotherapy.

Main Methods:

• Literature review of recent research on TACAs-based anticancer vaccines.
• Analysis of different approaches to enhance TACA immunogenicity.
• Synthesis of findings on the efficacy and challenges of TACAs-based vaccines.

Main Results:

• TACAs are crucial targets in cancer immunotherapy due to their presence on cancer cells.
• Poor immunogenicity and immunotolerance of TACAs present significant challenges.
• Various strategies are being explored to enhance the immune response against TACAs.

Conclusions:

• TACAs-based vaccines hold significant potential for cancer immunotherapy.
• Overcoming immunotolerance and enhancing immunogenicity are critical for vaccine development.
• Continued research in TACAs-based vaccines is essential for advancing cancer treatment.